As of 2026-03-22, the Fair Value of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is -22.11 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.93 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd is -347.57%.
With the market price of 8.93 USD and our fair value calculation, Biohaven Pharmaceutical Holding Company Ltd (BHVN) is not a good investment. Investing in BHVN stocks now will result in a potential loss of 347.57%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -213.80 | -570.28 | -408.17 | -846.42 | -738.82 | -555.50 |
| YoY growth | -80.16% | -166.74% | 28.43% | -107.37% | 12.71% | -62.63% |
| Market Cap (mil) | 1,492.14 |
| P/E | |
| Forward P/E |
| EPS | -4.42 |
| Avg earnings growth rate | -62.63% |
| TTM earnings | -738.82 |